Friends Applauds Senate for FDA User Fee Bill Passage; Urges President Trump to Quickly Sign Into Law Washington, DC – August 3, 2017 – Friends of Cancer Research (Friends) applauds the Senate for voting overwhelmingly (94-1) today to pass the FDA Reauthorization Act of 2017 (H.R. 2430). The bill will now go to President Trump…
Friends of Cancer Research Applauds This Nomination Washington, DC – June 14, 2017 – President Donald Trump has nominated Dr. Norman E. Sharpless to be the next director at the National Cancer Institute (NCI). He will be replacing acting director Dr. Doug Lowy at the largest division within the National Institutes of Health. “We would…
Amendment Provides Opportunity for Patients to More Easily Gain Access to Potentially Beneficial Experimental Therapies While in Development Friends of Cancer Research (Friends) would like to thank and applaud the work of Senators Orrin Hatch (R-UT), Michael Bennet (D-CO), Richard Burr (R-NC), and Bob Casey (D-PA) who once again showed their tireless commitment to patients…
Washington, DC, April 27, 2017 – Friends of Cancer Research (Friends) would like to thank Chairman Alexander and the Senate HELP Committee for voting to report Dr. Scott Gottlieb’s nomination to be FDA commissioner favorably to the full Senate for a vote. The committee vote was 14-9 in favor of moving the nomination forward. …
Washington, DC, April 20, 2017 – Friends of Cancer Research (Friends) Chairperson & Founder, Ellen V. Sigal, will receive the Face of Hope award at LUNGevity’s Celebration of Hope event tomorrow evening. The Face of Hope award is presented to an individual who recognizes the needs of those living with lung cancer and is actively…
Today, at 10am ET, Dr. Scott Gottlieb, the President’s nominee for FDA Commissioner, will appear before the Senate Health, Education, Labor and Pensions (HELP) Committee for his confirmation hearing. We will be live-tweeting the hearing: Follow us on Twitter for the latest Senate HELP will also be broadcasting the hearing via webcast The Advocacy…
Washington, DC, March 27, 2017 – Today, Friends of Cancer Research (Friends) launched a new online learning community, ProgressForPatients.org. The site is home to two new programs Friends has been developing over the course of the last year, Friends’ Advocacy Education and Advocacy Alliance. “We set out to create an online community, a place where…
The first House PDUFA reauthorization hearing is scheduled to take place at 10:15 am ET today, Wednesday, March 22, 2017, in the U.S. House of Representatives. Friends of Cancer Research President & CEO Dr. Jeff Allen will testify as to the importance of user fees during today’s hearing, along with FDA’s Dr. Janet Woodcock and…
Washington, D.C., March 21, 2017—The National Organization for Rare Disorders (NORD) and Friends of Cancer Research, two leading organizations that collectively represent millions of Americans with cancer and rare diseases, issued the following statement in advance of this week’s congressional hearings on the reauthorization of FDA user fees: “We wish to congratulate the Senate Committee…
President Nominates Dr. Scott Gottlieb for FDA Commissioner Friends Urges Swift Confirmation Washington, DC, March 10, 2017 – Friends of Cancer Research (Friends) strongly supports President Trump’s nomination of Dr. Scott Gottlieb to serve as the next FDA Commissioner and urges Congress to work quickly to confirm his appointment. “We deeply respect Dr. Gottlieb and have…
